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Oreochromis niloticusThe current study was designed to investigate the potential effect of Spirulina platensis, Arthro-
spira platensis, (SP) on tissue protection of Nile tilapia (Oreochromis niloticus) through estima-
tion of P53 level. Five isonitrogenous and isocaloric rations containing graded levels of dried SP
5, 7.5,10, 15, and 20 g/kg diet were fed separately to ﬁve equal groups of O. niloticus ﬁngerlings,
additional control group was assigned for 3 months. Liver samples were separately collected
from each group by the end of each month. The expression level of P53 showed a substantial
decrease among the treated groups in a time-dependent manner. It is therefore advisable to
incorporate SP in diets for tissue protection and antioxidant effects in cultured O. niloticus.
ª 2014 Cairo University. Production and hosting by Elsevier B.V. All rights reserved.Introduction
Tilapias are among the easiest and most proﬁtable ﬁsh candi-
date to aqua-farm [1], being omnivorous render it susceptible
to utilize cyanobacterial blue-green algae [2]. Using feeds in
aquaculture generally increases both cost and productivity
and hence there is a vital need to seek effective ingredients thatcan either partially or totally replace expensive ingredients as
protein sources [3].
Spirulina platensis (SP), a nutritionally enriched ﬁlamen-
tous cyanobacterium, possesses diverse biological and nutri-
tional signiﬁcance having bio-modulatory and immuno-
modulatory functions. [4] Algae gained attention as a possible
alternative protein source for cultured ﬁsh, particularly in
tropical and subtropical regions where algae production is high
[5]. SP is well known for its anti-oxidant and anti-cancerous
properties as well as its ability to amend the carcinogen-dam-
aged DNA [6,7].
The P53 protein is the founding member of a family of pro-
teins that regulate cell cycle progression, differentiation, and
apoptosis [8]. The P53 gene product is a DNA sequence-spe-
ciﬁc transcription factor, which as a homotetramer controls
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with response elements [8]. Many studies proved that P53 has
regulatory responses to a variety of cellular stresses, including
DNA damage, nucleotide depletion, chemotherapeutic drugs
and oxidative stress, genotoxic damages, oncogene activation,
and hypoxia [9–11]. Activation of P53 can induce several re-
sponses, including DNA repair, senescence, differentiation,
and inhibition of angiogenesis [12]. The P53 acts biochemically
as a transcription factor and biologically as a powerful tumor
suppressor. The loss of the protective P53 cellular mechanism
may eventually result in cancer progression [12]. The major
function for the P53 tumor suppressor is to restrict abnormal
or stress-exposed cells before damaged DNA converted to
inherited mutation [13]. However, even without extended
stress, the DNA is exposed to endogenous damaging reactive
oxygen species (ROS), which are the by-products of normal
respiration, and important signaling molecules [14].
None of the previous studies explored the potential effects
of SP as an anti-oxidant agent in Oreochromis niloticus. The
aim of the present work was therefore to estimate the in vitro
potential effects of SP as a chemoprotective agent in O. niloti-
cus through estimation of P53 expression level.
Material and methods
Fish
A total of 2400 O. niloticus fries (mean individual initial weight
4 ± 1.0 g) were divided into six equal groups, each consisting
of four replicates (100 fry/replicate) in 6 separate earthen
ponds. Fish in each replicate were reared in a hapa made of
cotton mesh like a cage (3 · 2 · 1 m, each) that was ﬁxed in
an earthen pond (for each group, a total of 4 hapas were
equally arranged in 4 rows). The ﬁsh were fed twice daily on
a basal diet of 35% protein at 10% of body weight per day.
The feed was placed in plastic trays ﬁtted in the hapas (1 per
hapa). The water was partially renewed daily and monitored
regularly and maintained at 25 ± 1 C. The whole experimen-
tal work was carried out at the experimental units of The
World Fish Center (Abbasa, Sharkia, Egypt) and was
approved by ethical committee of Faculty of Veterinary
Medicine, Cairo University.
S. platensis (SP)
Pure dried SP tablets were obtained from Lake Heath Prod-
ucts Co., Ltd. (Liyang City, Jiangsu Province, China). The tab-
lets were grounded to a powder form before usage.
Rations
A standard commercial ration containing crude protein, crude
lipid, vitamins, and minerals that met the basic dietary require-
ments of O. niloticus was prepared as shown in Table 1. The
ingredients were mixed mechanically at room temperature by
horizontal mixer (Hobarts model D300-T, Troy, OH, USA).
SP treated diets were prepared by mixing separately a graded
concentration of SP at 5, 7.5, 10, 15, and 20 g/kg diet. The pel-
lets were then prepared using a pellet-machine (California Pel-
let Mill, Roskamp Huller Co., California, USA) with 0.5 cmdiameter. The pellets were left for 24 h for air-drying at room
temperature (26 C), broken into small pieces, and sieved to
obtain the appropriate size. The rations were transferred into
plastic bags and stored in a refrigerator at 4 C until used.
The last group was assigned to a control ration and received
the standard commercial pellet without any treatment. The re-
quired diet was prepared biweekly and stored in a refrigerator
(4 C) for daily use.
Experimental design
Three months feeding study periods were conducted to evalu-
ate the efﬁcacy of SP as a chemoprotective agent in cultured O.
niloticus. The pre-acclimated ﬁsh were divided into 6 equal
groups. Group 1 was fed on a basal diet (control) and the other
groups were dietary supplemented with a single graded concen-
tration of dried SP at 5, 7.5, 10, 15, and 20 g kg1 diet fed,
respectively. At the end of each month, the P53 expression le-
vel relative to control was estimated in liver of experimental
groups.
Tissue sampling
By the end of each month; liver specimens were collected from
ﬁsh representing each treatment separately. Samples were col-
lected in sterile 0.5 ml cryotubes, freeze, and stored at 80 C
until used.
Total RNA extraction and cDNA synthesis
Total RNA isolation was performed using QIAmp RNA mini
kit (Qiagen, Hilden, Germany) according to the manufacturer
manual. The isolated RNA was used in cDNA synthesis using
reverse transcriptase (Fermentas, EU).
Real-time PCR (qPCR)
The reaction mixture consisted of 1 ll cDNA, 0.5 mM of each
primer (P53 and GAPDH as internal control), iQ SYBR
GREEN PERMIX (BIO-RAD 170–880, USA) in a total vol-
ume of 20 ll. PCR ampliﬁcation and analysis were achieved
using BIO-RAD iCycler thermal cycler and the MyiQ real-
time PCR detection system. All templates were ampliﬁed using
the following Light Cycler protocol. The primer for P53 was
based on the sequence published in gene bank FJ233106.1
for O. niloticus; forward primer; GCATGTGGCT-
GATGTTGTTC and the reverse one GCAGGATGGTGGT-
CATCTCT. The fast start polymerase was activated and
cDNA denatured by a pre-incubation for 10 min at 95 C,
the template was ampliﬁed for 40 cycles of denaturation pro-
gramed for 20 s at 95 C, annealing of primers at 60 C pro-
gramed for 20 s, and extension at 72 C programed for 30 s.
Fluorescent data were acquired during each extension phase.
Each assay includes triplicate samples for each tested cDNAs
and no-template negative control [15].
The DCT value is calculated by the subtraction of the GAP-
DH CT from each P53 CT.
 The DDCT value is calculated by subtraction of the control
DCT from each P53 DCT.
Table 3 Results of statistical analysis of P53 expression level:
Mean, Std. Error of groups, and duration of experimental
feeding trials of Oreochromis niloticus with PS.
Group Mean Std. Error
Group 2 (5 g/kg) 1.313 0.280
Group 3 (7.5 g/kg) 0.600 0.280
Group 4 (10 g/kg) 0.513 0.280
Group 5 (15 g/kg) 0.550 0.280
Group 6 (20 g/kg) 0.520 0.280




Based on sample size for groups = 5 and sample size for months 3.
Table 1 Composition of the Oreochromis niloticus basal diet used throughout the experiment.
Ingredients Diet (%) Protein (%) Metabolic energy (J)
Ingredients Feed Ingredients Feed
Fish meal 7.95 0.72 5.76 4000 32,000
Soybean meal 52.8 0.48 25.39 2870 151,823
Ground corn 29.1 0.10 3.17 1240 36,084
Wheat ﬂour 5.00 0.13 0.67 2700 13,500
Vegetable oil 2.00 0.00 0.00 9100 18,200
Cod liver oil 2.00 0.00 0.00 9100 18,200
Di calcium phosphate 1.00 0.00 0.00 0.00 0000
Mineral mix. 0.07 0.00 0.00 0.00 0000
Vitamin mix. 0.05 0.00 0.00 0.00 0000
Total 100 0.00 34.99 0.00 269,807
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Statistical analysis
A two way ANOVA model followed by post-Hoc test MCT
(LSD) was used for data analysis. The computation was exe-
cuted on SPSS program version 15 and a P value less than
5% is considered signiﬁcant (p< 0.05).
Results
The expression level of P53 showed a decline pattern among
the treated groups relative to the control group (Table 2).
The two way ANOVA analysis based on F test showed a P va-
lue of 0.284 between groups, which is not signiﬁcant. There
were observed differences between groups receiving different
concentrations of SP; however, it was not sufﬁcient enough
to be signiﬁcant. LSD between time showed a signiﬁcant dif-
ference between ﬁrst month and third month with a P value
equal 0.025 (< 0.05) (Table 3).
Discussion
Among the diverse biological activities and nutritional signiﬁ-
cance of Spirulina, their capability to inhibit carcinogenesis via
its anti-oxidant properties has been previously reported [6].
Based on two ways ANOVA statistical analysis test, we found
that SP could produce a chemoprotective action in O. niloticus
when supplemented in the ration for at least 2 months regard-
less the dose administered to ﬁsh.Table 2 Results of P53 expression level relative to control in
Oreochromis niloticus fed PS for 3 months.
First month Second month Third month
Group 2 (5 g/kg) 1.0 2.3 0.64
Group 3 (7.5 g/kg) 1.1 0.37 0.33
Group 4 (10 g/kg) 1.1 0.31 0.13
Group 5 (15 g/kg) 1.2 0.34 0.11
Group 6 (20 g/kg) 1.1 0.34 0.12The ﬁndings of the present study are consistent with the
growing body evidence indicating that in addition to the
P53-dependent transcriptional program, its known inﬂuence
on apoptosis and cell cycle arrest enhances the expression of
key regulators of innate immunity pathways [16]. P53 may ex-
tend its protective function by participating in antioxidant de-
fense. Such activity should be at variance to the known pro-
oxidant function of some stress-induced P53-responsive genes,
which contribute to P53-induced cell death [17]. All these ﬁnd-
ings suggest that the highly conserved nature of P53 among
eukaryotes may rely more on its role in host immunity rather
than its functions as a tumor suppressor gene [18].
The functions of the P53 tumor suppressor that restrict pro-
liferation of abnormal cells are activated by stresses presuming
that under normal conditions, P53 is dormant. However, P53
might have additional non-restrictive functions addressing
physiological stresses, which produce repairable injuries. One
of the emerging protective functions of P53 is the enhancement
of DNA repair [19]. Taura et al. noticed that in addition to P53
down-regulates intracellular ROS levels (thus reducing proba-
bility of genetic alterations), the antioxidant function was not
expected as P53 was known as a potent pro-oxidant inducing a
set of ROS-generating genes, which contribute to apoptosis.
However, the anti-oxidant function of P53 is mediated through
a set of antioxidant genes, which are responsive to lower levels
of P53 in non-stressed or physiologically-stressed cells [20]. We
propose that the antioxidant function of P53 represent an
important component of its suppressor activity, which de-
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vival and repair of cells with minor cellular injuries [21,22].
Also, the ﬁndings of our study can be assisted by the reports
proved the P53-dependent enhancement of interferon regula-
tory factor (IFN) signaling and other genes involved in innate
immunity including IRF5, antiviral genes such as ISG15 and
double stranded RNA (dsRNA)-activated protein kinase R
(PKR), and pro-inﬂammatory chemokines such as monocyte
chemoattractant protein 1 (MCP-1) [23].
Conclusion
We could conclude that the incorporation of dried SP was use-
ful to positively improve the health conditions of Nile tilapia
through tissue protection and anti-oxidant effects of SP via
estimation of P53 expression level. It is recommended to sup-
plement Spirulina in the diet of Nile tilapia especially those
grow in farms under immunosuppressive/stressful conditions.
The supplementation must be for a minimum of 2 months to
exert its beneﬁcial effects. Additional researches are needed
to study the possible additional desired effects of the blue-
green algae in cultured ﬁsh.
Conﬂict of interest
The authors have declared no conﬂict of interest.
References
[1] Parker R, Parker RO. Aquaculture science; 2011. p. 123–8
[Cengage learning ISBN 9781435488120].
[2] Chow CY, Woo NYS. Bioenergetics studies on an omnivorous
ﬁsh Oreochromis mossambicus: evaluation of the utilization of
Spirulina platensis algae in feed. In: Hirano R, Hanyu I, editors.
Proceeding of the 2nd Asian ﬁsheries forum. Manila: The
Asian Fisheries Society; 1990. p. 291–4.
[3] Huntington TC, Hasan MR. Fish as feed inputs for aquaculture
– practices, sustainability and implications: a global synthesis.
In: Hasan MR, Halwart M, editors. Fish as feed inputs for
aquaculture: practices, sustainability and implications. FAO
ﬁsheries and aquaculture technical paper. No. 518. Rome, FAO;
2009. p. 1–61.
[4] Khan Z, Bhadouria P, Bisen PS. Nutritional and therapeutic
potential of Spirulina. Curr Pharm Biotechnol 2005;6(5):373–9.
[5] El-Hindawy MM, Abd-Razic MA, Gaber HA, Zenhom MM.
Effect of various level of dietary algae Scenedesmus spp on
physiological performance and digestibility of Nile tilapia
ﬁngerlings. In: 1st Scientiﬁc conference of the Egyptian
aquaculture society. Sharm El-Sheikh – Sinai, Egypt; 2006; p.
137–49.
[6] Romay C, Gonza´lez R, Ledo´n N, Remı´rez D, Rimbau V. C-
phycocyanin: a biliprotein with antioxidant, anti-inﬂammatory
and neuroprotective effects. Curr Protein Pept Sci
2003;4:207–16.[7] Kaji T, Fujiwara Y, Inomata Y, Hamada C, Yamamoto C,
Shimada S, et al. Repair of wounded monolayers of cultures
bovine aortic endothelial cells is inhibited by calcium spirulan, a
novel sulfated polysaccharide isolated from Spirulina platensis.
Life Sci 2002;70:1841–8.
[8] Mills AA. P53: link to the past bridge to the future. Gene Dev
2005;19:2091–9.
[9] Inoue T, Wu L, Stuart J, Maki CG. Control of P53 nuclear
accumulation in stressed cells. FEBS Lett 2005;579:4978–84.
[10] Pang QS, Guo BJ, Ruan JH. Enhancement of endonuclease
activity and repair DNA synthesis by polysaccharide of
Spirulina platensis. Yi Chuan Xue Bao 1988;15:374–81.
[11] Grawish ME. Effects of Spirulina platensis extract on Syrian
hamster cheek pouch mucosa painted with 7, 12-dimethylbenz[a]
anthracene. Oral Oncol 2008;44:956–62.
[12] Sidransky D, Mikkelsen T, Schwechheimer K, Rosenblum ML,
Cavanee W, Vogelstein B. Clonal expansion of P53 mutant cells
is associated with brain tumour progression. Nature
1992;355:846–7.
[13] Doherty PC, Turner SJ, Webby RG, Thomas PG. Inﬂuenza and
the challenge for immunology. Nat Immunol 2006;7:449–55.
[14] Kasturi SP, Skountzou I, Albrecht RA, Koutsonanos D, Hua T,
Nakaya HI, et al. Programming the magnitude and persistence
of antibody responses with innate immunity. Nature
2011;470(7335):543–7.
[15] Livak KJ, Schmittgen HD. Analysis of relative gene expression
data using real-time quantitative PCR and the 2–2DDCT
method. Methods 2001;25:402–8.
[16] Mori T, Anazawa Y, Iiizumi M, Fukuda S, Nakamura Y,
Arakawa H. Identiﬁcation of the interferon regulatory factor 5
gene (IRF-5) as a direct target for p53. Oncogene
2002;21:2914–8.
[17] Macip S, Igarashi M, Berggren P, Yu J, Lee SW, Aaronson SA.
Inﬂuence of induced reactive oxygen species in P53-mediated cell
fate decisions. Mol Cell Biol 2003;23:8576–85.
[18] Mun˜oz-Fontela C, Pazos M, Delgado I, Murk W, Mungamuri
S, Sam W, et al. P53 serves as a host antiviral factor that
enhances innate and adaptive immune responses to inﬂuenza A
virus. J Immunol 2011;187(12):6428–36.
[19] Achanta G, Huang P. Role of P53 in sensing oxidative DNA
damage in response to reactive oxygen species-generating agents.
Cancer Res 2004;64:6233–9.
[20] Taura M, Eguma A, Suico MA, Shuto T, Koga T, Komatsu K,
et al. P53 regulates toll-like receptor 3 expression and function
in human epithelial cell lines. Mol Cell Biol 2008;28:6557–67.
[21] Seo YR, Jung HJ. The potential roles of P53 tumor suppressor
in nucleotide excision repair (NER) and base excision repair
(BER). Exp Mol Med 2004;36:505–9.
[22] Munoz-Fontela C, Macip S, Martinez-Sobrido L, Brown L,
Ashour J, Garcia-Sastre A, et al. Transcriptional role of P53 in
interferon-mediated antiviral immunity. J Exp Med
2008;205:1929–38.
[23] Yanai H, Chen HM, Inuzuka T, Kondo S, Mak TW, Takaoka
A, et al. Role of IFN regulatory factor 5 transcription factor in
antiviral immunity and tumor suppression. Proc Nat Acad Sci
USA 2007;104:3402–7.
